Chapter E - Chapter
from Drugs: An A–Z Guide
Published online by Cambridge University Press: 18 July 2019
Summary
Enoxaparin is a widely used LMWH, similar to dalteparin but in comparison it has a longer half-life (7 versus 3–4 hours, respectively).
The incidence of bleeding is similar between LMWHs and unfractionated heparin. The incidence of immune-mediated thrombocytopenia is about 2–3% of patients treated with unfractionated heparin. LMWHs are preferred over unfractionated heparin because they are as effective, simplify treatment (usually once-daily dosing, no IV cannulation), have a lower risk of HIT and monitoring is not required.
- Type
- Chapter
- Information
- Handbook of Drugs in Intensive CareAn A-Z Guide, pp. 107 - 118Publisher: Cambridge University PressPrint publication year: 2019